Iron deficiency in pulmonary vascular disease: pathophysiological and clinical implications.
Eur Heart J
; 44(22): 1979-1991, 2023 Jun 09.
Article
en En
| MEDLINE
| ID: mdl-36879444
ABSTRACT
AIMS:
Iron deficiency is common in pulmonary hypertension, but its clinical significance and optimal definition remain unclear. METHODS ANDRESULTS:
Phenotypic data for 1028 patients enrolled in the Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics study were analyzed. Iron deficiency was defined using the conventional heart failure definition and also based upon optimal cut-points associated with impaired peak oxygen consumption (peakVO2), 6-min walk test distance, and 36-Item Short Form Survey (SF-36) scores. The relationships between iron deficiency and cardiac and pulmonary vascular function and structure and outcomes were assessed. The heart failure definition of iron deficiency endorsed by pulmonary hypertension guidelines did not identify patients with reduced peakVO2, 6-min walk test, and SF-36 (P > 0.208 for all), but defining iron deficiency as transferrin saturation (TSAT) <21% did. Compared to those with TSAT ≥21%, patients with TSAT <21% demonstrated lower peakVO2 [absolute difference -1.89 (-2.73 to -1.04) mL/kg/min], 6-min walk test distance [absolute difference -34 (-51 to -17) m], and SF-36 physical component score [absolute difference -2.5 (-1.3 to -3.8)] after adjusting for age, sex, and hemoglobin (all P < 0.001). Patients with a TSAT <21% had more right ventricular remodeling on cardiac magnetic resonance but similar pulmonary vascular resistance on catheterization. Transferrin saturation <21% was also associated with increased mortality risk (hazard ratio 1.63, 95% confidence interval 1.13-2.34; P = 0.009) after adjusting for sex, age, hemoglobin, and N-terminal pro-B-type natriuretic peptide.CONCLUSION:
The definition of iron deficiency in the 2022 European Society of Cardiology (ESC)/European Respiratory Society (ERS) pulmonary hypertension guidelines does not identify patients with lower exercise capacity or functional status, while a definition of TSAT <21% identifies patients with lower exercise capacity, worse functional status, right heart remodeling, and adverse clinical outcomes.Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Anemia Ferropénica
/
Deficiencias de Hierro
/
Insuficiencia Cardíaca
/
Hipertensión Pulmonar
Tipo de estudio:
Guideline
/
Prognostic_studies
/
Qualitative_research
Límite:
Humans
Idioma:
En
Revista:
Eur Heart J
Año:
2023
Tipo del documento:
Article
País de afiliación:
Estados Unidos